Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Alnylam Pharmaceuticals has the lowest figure of the 61 pharmaceutical companies ranked by one-year price change, at -66.0%, followed by Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Alnylam Pharmaceuticals-66.0%
- Median
- +26.9%
- Combined market value
- ZAR 87.75T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | ZAR 350.3B | ZAR 2,615.57 | 3.12% down | 66% down | ||
| 2 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | ZAR 78.8B | ZAR 472.86 | 1.67% up | 64% down | ||
| 3 | Legend BiotechLEGN · Health Care | -42.5% | ZAR 54.3B | ZAR 279.99 | 0.74% up | 42% down | ||
| 4 | InsmedINSM · Health Care | -40.1% | ZAR 455.3B | ZAR 2,075.26 | 1.28% down | 40% down | ||
| 5 | Summit TherapeuticsSMMT · Health Care | -35.6% | ZAR 146.4B | ZAR 183.04 | 0.56% down | 36% down | ||
| 6 | ZoetisZTS · Health Care | -28.7% | ZAR 588.6B | ZAR 1,448.51 | 0.58% up | 29% down | ||
| 7 | ABIVAXABVX · Health Care | -27.3% | ZAR 126.3B | ZAR 1,442.39 | 1.84% up | 27% down | ||
| 8 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | ZAR 162.5B | ZAR 6,994.93 | 3.91% down | 24% down | ||
| 9 | Cogent BiosciencesCOGT · Health Care | -20.3% | ZAR 84.8B | ZAR 487.44 | 1.45% up | 20% down | ||
| 10 | CytokineticsCYTK · Health Care | -20.3% | ZAR 123.2B | ZAR 884.05 | 0.78% down | 20% down | ||
| 11 | PTC TherapeuticsPTCT · Health Care | -20.2% | ZAR 87B | ZAR 1,041.12 | 0.02% down | 20% down | ||
| 12 | Abbott LaboratoriesABT · Health Care | -17.0% | ZAR 3.14T | ZAR 1,810.36 | 0.22% up | 17% down | ||
| 13 | Novo NordiskNVO · Health Care | -16.9% | ZAR 3.01T | ZAR 682.12 | 2.85% down | 17% down | ||
| 14 | Corcept TherapeuticsCORT · Health Care | -7.92% | ZAR 128.5B | ZAR 1,173.96 | 2.88% down | 8% down | ||
| 15 | Axsome TherapeuticsAXSM · Health Care | -7.37% | ZAR 121.5B | ZAR 2,310.65 | 1.48% down | 7% down | ||
| 16 | SanofiSNY · Health Care | -4.08% | ZAR 1.96T | ZAR 816.25 | 0.45% down | 4% down | ||
| 17 | GrifolsGRFS · Health Care | +1.41% | ZAR 100B | ZAR 146.90 | 1.33% down | 1% up | ||
| 18 | AstraZenecaAZN · Health Care | +2.41% | ZAR 4.8T | ZAR 3,093.18 | 1.63% down | 2% up | ||
| 19 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | ZAR 215.5B | ZAR 258.51 | 1.32% up | 5% up | ||
| 20 | GSKGSK · Health Care | +6.26% | ZAR 1.69T | ZAR 841.70 | 0.91% down | 6% up | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | ZAR 104.9B | ZAR 742.16 | 0.07% up | 10% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | ZAR 201.5B | ZAR 1,040.09 | 3.04% up | 11% up | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | ZAR 140B | ZAR 2,019.62 | 0.39% up | 13% up | ||
| 24 | PfizerPFE · Health Care | +14.4% | ZAR 2.77T | ZAR 486.23 | 1.00% down | 14% up | ||
| 25 | BeOne MedicinesONC · Health Care | +16.8% | ZAR 794.3B | ZAR 6,953.35 | 2.47% down | 17% up | ||
| 26 | BridgeBio PharmaBBIO · Health Care | +17.2% | ZAR 260.9B | ZAR 1,339.57 | 1.11% up | 17% up | ||
| 27 | Elanco Animal HealthELAN · Health Care | +20.5% | ZAR 228.2B | ZAR 456.47 | 2.36% up | 20% up | ||
| 28 | United TherapeuticsUTHR · Health Care | +22.6% | ZAR 425.1B | ZAR 9,982.18 | 0.94% down | 23% up | ||
| 29 | NovartisNVS · Health Care | +25.0% | ZAR 5.08T | ZAR 2,689.84 | 2.02% down | 25% up | ||
| 30 | AbbVieABBV · Health Care | +25.7% | ZAR 8.82T | ZAR 4,988.07 | 1.26% down | 26% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | ZAR 2.34T | ZAR 9,234.16 | 0.20% up | 27% up | ||
| 32 | Ascendis PharmaASND · Health Care | +27.8% | ZAR 306.7B | ZAR 4,676.34 | 0.04% down | 28% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | ZAR 103B | ZAR 1,577.64 | 0.54% down | 31% up | ||
| 34 | Belite BioBLTE · Health Care | +31.0% | ZAR 110.8B | ZAR 2,727.96 | 0.26% up | 31% up | ||
| 35 | Bristol-Myers SquibbBMY · Health Care | +34.0% | ZAR 2.12T | ZAR 1,038.71 | 1.86% down | 34% up | ||
| 36 | Eli LillyLLY · Health Care | +34.9% | ZAR 21.31T | ZAR 23,921.24 | 2.04% down | 35% up | ||
| 37 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | ZAR 1.71T | ZAR 16,498.46 | 0.15% down | 36% up | ||
| 38 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | ZAR 270.3B | ZAR 4,211.50 | 1.42% up | 37% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | +37.6% | ZAR 11.45T | ZAR 4,757.25 | 1.05% down | 38% up | ||
| 40 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | ZAR 103.6B | ZAR 5,178.01 | 2.16% up | 43% up | ||
| 41 | Travere TherapeuticsTVTX · Health Care | +44.2% | ZAR 83.3B | ZAR 867.83 | 1.56% down | 44% up | ||
| 42 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | ZAR 141.2B | ZAR 2,163.50 | 0.59% up | 46% up | ||
| 43 | Merck & CoMRK · Health Care | +50.8% | ZAR 5.94T | ZAR 2,408.99 | 2.60% down | 51% up | ||
| 44 | Takeda PharmaceuticalTAK · Health Care | +53.6% | ZAR 1.18T | ZAR 368.75 | 1.22% down | 54% up | ||
| 45 | AlkermesALKS · Health Care | +58.4% | ZAR 135.3B | ZAR 805.12 | 2.68% up | 58% up | ||
| 46 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | ZAR 147.3B | ZAR 5,268.41 | 0.11% up | 61% up | ||
| 47 | GenmabGMAB · Health Care | +70.0% | ZAR 544.6B | ZAR 883.27 | 1.46% down | 70% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | ZAR 850.7B | ZAR 729.04 | 0.84% down | 74% up | ||
| 49 | Royalty PharmaRPRX · Health Care | +77.7% | ZAR 683B | ZAR 1,187.93 | 0.26% up | 78% up | ||
| 50 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | ZAR 129.6B | ZAR 371.85 | 2.06% up | 83% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | ZAR 77.8B | ZAR 710.76 | 2.00% down | 88% up | ||
| 52 | Roivant SciencesROIV · Health Care | +90.3% | ZAR 480.9B | ZAR 663.66 | 0.62% down | 90% up | ||
| 53 | ViatrisVTRS · Health Care | +95.5% | ZAR 406.7B | ZAR 354.78 | 0.56% up | 96% up | ||
| 54 | TG TherapeuticsTGTX · Health Care | +107% | ZAR 170.2B | ZAR 1,126.17 | 4.10% up | 107% up | ||
| 55 | Dianthus TherapeuticsDNTH · Health Care | +113% | ZAR 84.3B | ZAR 1,496.13 | 0.29% down | 113% up | ||
| 56 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | ZAR 130.1B | ZAR 1,655.88 | 0.92% up | 126% up | ||
| 57 | Definium TherapeuticsDFTX · Health Care | +169% | ZAR 67.5B | ZAR 493.05 | 2.72% down | 169% up | ||
| 58 | VeradermicsMANE · Health Care | +233% | ZAR 90.3B | ZAR 2,140.29 | 1.25% down | 233% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | +241% | ZAR 112.9B | ZAR 1,664.59 | 0.18% up | 241% up | ||
| 60 | Spyre TherapeuticsSYRE · Health Care | +286% | ZAR 156.3B | ZAR 1,645.78 | 1.69% up | 286% up | ||
| 61 | ErascaERAS · Health Care | +403% | ZAR 79.4B | ZAR 226.17 | 5.62% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2514 ZAR).
Questions and answers
Which pharmaceutical companies have the lowest one-year price change?
Alnylam Pharmaceuticals (-66.0%), Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%) have the lowest one-year price change of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 16:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of ZAR 87.75T as of 18 Nov 2026, 16:47 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.